Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Vaccine|May 12, 2009
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacyCarla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, et al.Breast Cancer Research : BCR|May 23, 2015
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesisStefania Croci, Patrizia Nanni, Arianna Palladini, et al.Cancer Research|June 3, 2004
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccineCarla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, et al.Oncotarget|November 27, 2014
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasLorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, et al.The Journal of Clinical Investigation|March 3, 2004
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsElena Quaglino, Simona Rolla, Manuela Iezzi, et al.Plos Pathogens|February 6, 2013
Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirusPatrizia Nanni, Valentina Gatta, Laura Menotti, et al.Cancer Research|April 17, 2004
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic miceElena Quaglino, Manuela Iezzi, Cristina Mastini, et al.Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.International Journal of Cancer|February 10, 2007
Inhibition of prostate carcinogenesis by combined active immunoprophylaxisCarla De Giovanni, Stefania Croci, Giordano Nicoletti, et al.Human Molecular Genetics|October 29, 2013
Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairmentLuisa Iommarini, Ivana Kurelac, Mariantonietta Capristo, et al.Pageof 6